---
title: ROI Case Study
description: A cost-benefit case study for customers to estimate money and time saved with automated hazardous drug management.
---

[![Rpharmy TM](https://www.rpharmy.com/hubfs/Rpharmy%20TM.svg)

](https://www.rpharmy.com/?hsLang=en)

## ROI Case Study

Based on interviews with customers, this resource helps you better understand and easily communicate the actual amount of time and staff required for tasks required for the HD communication plan in USP <800>.

[![Rhazdrugs+Cost+Benefit+Case+Study (1)_Page_1](https://6609875.fs1.hubspotusercontent-na1.net/hub/6609875/hubfs/Rhazdrugs%2BCost%2BBenefit%2BCase%2BStudy%20(1)_Page_1.jpg?width=1200&length=1200&name=Rhazdrugs%2BCost%2BBenefit%2BCase%2BStudy%20(1)_Page_1.jpg) ](https://www.rpharmy.com/hubfs/Rhazdrugs+Cost+Benefit+Case+Study%20(1).pdf?hsLang=en)

*Page 1 of 3. *Click on the image to download the Rhazdrugs ROI Case Study. 

[![Rhazdrugs+Cost+Benefit+Case+Study (1)_Page_2](https://6609875.fs1.hubspotusercontent-na1.net/hub/6609875/hubfs/Rhazdrugs%2BCost%2BBenefit%2BCase%2BStudy%20(1)_Page_2.jpg?width=1200&length=1200&name=Rhazdrugs%2BCost%2BBenefit%2BCase%2BStudy%20(1)_Page_2.jpg) ](https://www.rpharmy.com/hubfs/Rhazdrugs+Cost+Benefit+Case+Study%20(1).pdf?hsLang=en)

*Page 2 of 3.* Click on the image to download the Rhazdrugs ROI Case Study. 

[![Rhazdrugs+Cost+Benefit+Case+Study (1)_Page_3](https://6609875.fs1.hubspotusercontent-na1.net/hub/6609875/hubfs/Rhazdrugs%2BCost%2BBenefit%2BCase%2BStudy%20(1)_Page_3.jpg?width=1200&length=1200&name=Rhazdrugs%2BCost%2BBenefit%2BCase%2BStudy%20(1)_Page_3.jpg) ](https://www.rpharmy.com/hubfs/Rhazdrugs+Cost+Benefit+Case+Study%20(1).pdf?hsLang=en)

*Page 3 of 3. *Click on the image to download the Rhazdrugs ROI Case Study. 

## Rhazdrugs

- [Rhazdrugs](https://www.rpharmy.com/rhazdrugs?hsLang=en)
- [Rhazdrugs 2-Minute Introduction Video](https://www.rpharmy.com/rhazdrugs-2-minute-intro-video?hsLang=en)
- [Rhazdrugs FAQs](https://www.rpharmy.com/rhazdrugs-faqs?hsLang=en)
- [Hazardous Drugs Resources](https://www.rpharmy.com/hazardous-drugs-resources-page?hsLang=en)
- [Recently Added Hazardous Drugs](https://www.rpharmy.com/en-us/recently-added-hazardous-drugs?hsLang=en)
- [USP <800> Lunch + Learn Webinar Videos](https://www.rpharmy.com/usp-800-lunch-and-learn-videos?hsLang=en)
- [What is USP <800>?](https://www.rpharmy.com/rhazdrugs-3?hsLang=en)
- [ROI Case Study for Rhazdrugs](https://www.rpharmy.com/roi_case_study?hsLang=en)

[![Request Demo](https://no-cache.hubspot.com/cta/default/6609875/493f23e5-7a24-4167-891f-a40d98f99a5c.png)](https://cta-redirect.hubspot.com/cta/redirect/6609875/493f23e5-7a24-4167-891f-a40d98f99a5c)

<https://www.rpharmy.com/?hsLang=en>

PO Box 340220  
Austin TX 78734

info@rpharmy.com[tel:+18004671907](tel:+18004671907)

<https://www.linkedin.com/company/rpharmy/> <https://x.com/rpharmy> <https://www.youtube.com/@rpharmy> <https://www.facebook.com/rpharmy>

[![texas historically underutilized business program certified](https://www.rpharmy.com/hs-fs/hubfs/texas%20historically%20underutilized%20business%20program%20certified.png?width=126&height=109&name=texas%20historically%20underutilized%20business%20program%20certified.png)](https://www.rpharmy.com/blog/womanownedbusiness?hsLang=en)

© 2026 Rpharmy. All Rights Reserved. [Privacy Policy](https://www.rpharmy.com/roi_case_study#)